Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
YM177 (Celecoxib) in Postoperative Pain
NCT01118572Phase 3Completed
- Sponsor
- Astellas Pharma
- Start
- Feb 2010
- Primary completion
- Nov 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of celecoxib oral solution in postoperative pain (3 arms), sponsored by Astellas Pharma. Primary endpoint: Patient impressions (4-categorical assessments) at 2 days. Started Feb 2010; status: completed.
02
Drugs
celecoxib oral solution
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT01118572.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01118572.